CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 22,000 shares at $7.71 ($169,671)
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale Director sold 22,000 shares at $5.93 ($130,383)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Other events
- 4 Planned sale 10% owner sold 191,854 shares at $5.98 ($1,147,786)
- 4 Planned sale Director sold 22,000 shares at $6.00 ($132,070)
- 4 Planned sale 10% owner sold 189,431 shares at an average $6.41 ($1,213,667)
- 4 Planned sale 10% owner sold 463,774 shares at an average $6.27 ($2,906,278)
- 144 Insider Sale of Securities
- 4 Planned sale EVP & Chief Financial Officer sold 6,799 shares at $5.56 ($37,782)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, General Counsel, Corp Sec sold 2,385 shares at $5.16 ($12,307)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- 4 Planned sale EVP and General Counsel sold 1,365 shares at $5.86 ($8,003)
- 4 Planned sale Director sold 22,000 shares at $5.64 ($124,047)
Page 6 of 41 · 806 filings